Alma Life Science Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 04-01-2025
- Paid Up Capital ₹ 5.00 M
as on 04-01-2025
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue -88.44%
(FY 2022)
- Profit 2.28%
(FY 2022)
- Ebitda -0.68%
(FY 2022)
- Net Worth -24.91%
(FY 2022)
- Total Assets -31.44%
(FY 2022)
About Alma Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amrut Chaudhari, Dipak Dhameliya, and Nileshkumar Mehta serve as directors at the Company.
- CIN/LLPIN
U24100GJ2015PTC085271
- Company No.
085271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2015
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alma Life Science Private Limited offer?
Alma Life Science Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Face Wash.
Who are the key members and board of directors at Alma Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amrut Chaudhari  | Director | 07-Dec-2015 | Current |
| Dipak Dhameliya | Director | 07-Dec-2015 | Current |
| Nileshkumar Mehta | Director | 07-Dec-2015 | Current |
Financial Performance of Alma Life Science.
Alma Life Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 88.44% decrease. The company also saw a slight improvement in profitability, with a 2.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alma Life Science?
Unlock access to Alma Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Abhelfen Life Science Private LimitedActive 4 years 7 months
Amrut Chaudhari and Nileshkumar Mehta are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Alma Life Science?
Unlock and access historical data on people associated with Alma Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alma Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alma Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
